Skip to main content

Advertisement

Log in

Management of high-grade retroperitoneal liposarcomas: personal experience

  • Original Article
  • Published:
Updates in Surgery Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Sarcomas are uncommon malignant tumors arising from mesenchymal tissue, accounting for approximately 10% of soft-tissue sarcomas and less than 1% of all malignant neoplasms. The most frequent subtypes of retroperitoneal sarcomas are liposarcoma. Total surgical extirpation appears the only chance for patient cure since medical therapies have shown little efficacy. We have analyzed our series of 32 retroperitoneal liposarcoma that undergone surgical resection and with at least 5 years of follow-up. We have included 21 patients who underwent a complete resection (R0) and 6 patients who underwent an incomplete resection (R1). However, the operation’s goal was a complete tumor resection with tumor-free resection margins. The 5-year survival was 85.7% when we performed a R0 resection, while it was 33.3% when we performed a R1 resection with a significant statistical difference (p = 0.02). Surgery is the gold standard for treatment of liposarcoma. Despite advances in diagnostic modalities, surgical techniques and the adoption of more aggressive procedure, such disease still has a propensity for local recurrence, even after an apparent complete resection. Therefore, locoregional recurrence remains the main cause of death in patients with a retroperitoneal liposarcoma. Moreover when the tumor recurs locally, the treatment of choice is to remove the recurrence. Our experience shows that a complete resection of primary lesions and further resection of recurrences early detected with CT examination could improve the overall survival of patients with retroperitoneal liposarcoma. Moreover in our series, the patients who undergo R1 resection had a worse prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Storm FK, Mahvi DM (1991) Diagnosis and management of retroperitoneal soft tissue sarcomas. Ann Surg 214:2–10

    Article  PubMed  CAS  Google Scholar 

  2. Hassan I, Park SZ, Donohue JH, Nagorney DM, Kay PA, Nasciemento AG, Schleck CD, Ilstrup DM (2004) Operative management of primary retroperitoneal sarcomas. a reappraisal of an institutional experience. Ann Surg 239(2):244–250

    Article  PubMed  Google Scholar 

  3. Jaques DP, Coit DG, Hajdu SI, Brenan MF (1990) Management of primary and recurrent softtissue sarcoma of the retroperitoneum. Ann Surg 212(1):51–59

    Article  PubMed  CAS  Google Scholar 

  4. Lewis JJ, Brennan MF (1996) Soft tissue sarcomas. Curr Probl Surg 33(10):817–872

    Article  PubMed  CAS  Google Scholar 

  5. Gholami S, Jacobs CD, Kapp DS, Parast LM, Norton JA (2009) The value of surgery for retroperitoneal sarcoma. Sarcoma. Article ID:605840 [Epub ahead of print]

  6. Lewis JJ, Leung D, Woodruff JM, Brennan MF (1998) Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 228:355–365

    Article  PubMed  CAS  Google Scholar 

  7. Herrera-Gomez A, Ortega-Gutiérrez C, Mohar Betancourt A, Luna-Ortiz K (2008) Giant retroperitoneal liposarcma. World J surg Oncol 6:115

    PubMed  Google Scholar 

  8. Sugarbaker PH (2001) Management of abdominopelvic sarcoma. In: Malawer MM, Sugarbaker PH (eds) Musculoskeletal cancer surgery treatment of sarcomas and allied diseases. Kluwer Academic Publishers, pp 147–163

  9. Doglietto GB, Tortorelli AP, Papa V, Rosa F, Bossola M, Prete FP, Covino M, Pacelli F (2007) Giant retroperitoneal sarcomas: a single institution experience. World J Surg 31(5):1047–1054

    Article  PubMed  Google Scholar 

  10. Di Matteo FM, De Stefano M, Vanni B, Palermo S, Biancafarina A, Giusti D, Giusti D, Savino G, Di Marco C, Casalvieri L, De Antoni E (2008) Retroperitoneal giant mixed sarcoma. Case report. G Chir 29(5):238–241

    PubMed  CAS  Google Scholar 

  11. An JY, Heo JS, Noh JH, Sohn TS, Nam SJ, Choi SH, Joh JW, Kim SJ (2007) Primary malignant retroperitoneal tumors: analysis of a single institutional experience. Eur J Surg Oncol 33(3):376–382

    Article  PubMed  CAS  Google Scholar 

  12. Fleming ID, Cooper JS, Henson DE, Hutter RVP (eds) (1997) American Joint Committee on Cancer Manual for Staging of Cancer. 5th edn, J.P. Lippincott, Philadelphia 149–1156

  13. Shiu MH, Brennan MF (eds) (1989) Surgical management of soft tissue sarcomas. Lea & Febiger, Philadelphia p 166

  14. Glenn J, Sindelar WF, Kinsella T, Glenn J, Sindelar WF, Kinsella T, Glatstein E, Tepper J, Costa J, Baker A, Sugarbaker P, Brennan MF, Seipp C et al (1985) Results of multimodality therapy of resecable soft tissue sarcomas of the retroperitoneum. Surgery 97:316–324

    PubMed  CAS  Google Scholar 

  15. Herman K, Kusv T (1999) Retroperitoneal sarcoma—the continued challenge for surgery and oncology. Surg Oncol 7:77–81

    Article  Google Scholar 

  16. Dalton RR, Donohue JH, Mucha P, van Heerden JA, Reiman HM, Chen SP (1989) Management of retroperitoneal sarcomas. Surgery 106:725–733

    PubMed  CAS  Google Scholar 

  17. Nathan H, Raut CP, Thornton K, Herman JM, Ahuja N, Schulick RD, Choti MA, Pawlik TM (2009) Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system. Ann Surg 250(6):970–976

    Article  PubMed  Google Scholar 

  18. McGrath PC (1994) Retroperitoneal sarcomas. Semin Surg Oncol 10:364–368

    Article  PubMed  CAS  Google Scholar 

  19. Sato T, Yamaguchi T, AzeKura K, Azekura K, Ueno M, Ohyama S, Ohya M, Yamamoto J, Muto T, Ishikawa Y, Kanda H (2006) Repeated resection for intra-abdominal and retroperitoneal liposarcomas: long-term experience in a single cancer center in Japan. Int Surg 91:267–271

    PubMed  Google Scholar 

  20. Greenall MJ, Magill GB, De Cosse JJ, Brennan MF (1986) Chemioterapy for soft tissue sarcoma. Surg Gynecol Obstet 162:193–198

    PubMed  CAS  Google Scholar 

  21. Thomas DM, O’Sullivan B, Gronchi A (2009) Current concepts and future perspectives in retroperitoneal soft-tissue sarcoma management. Expert Rev Anticancer Ther 9(8):1145–1157

    Article  PubMed  Google Scholar 

  22. Zhou Z, McDade TP, Simons JP, Ng SC, Lambert LA, Whalen GF, Shah SA, Tseng JF (2010) Surgery and radiotherapy for retroperitoneal and abdominal sarcoma: both necessary and sufficient. Arch Surg 145(5):426–431

    Article  PubMed  Google Scholar 

  23. Mc Grath PC, Neifeld JP, Lawrence W Jr, DeMay RM, Kay S, Horsley JS, Parker DA (1984) Improved survival following complete excision of retroperitoneal sarcomas. Ann Surg 200:200–204

    Google Scholar 

  24. Strauss DC, Hayes AJ, Thway K, Moskovic EC, Fisher C, Thomas JM (2010) Surgical management of primary retroperitoneal sarcoma. Br J Surg 97(5):698–706

    Article  PubMed  CAS  Google Scholar 

  25. Kim EY, Kim SJ, Choi D, Lee SJ, Kim SH, Lim HK, Song SY (2008) Recurrence of retroperitoneal liposarcoma: imaging findings and growth rates at follow-up CT. AJR 191:1841–1846

    Google Scholar 

  26. Bautista N, Su W, O’Connell TX (2000) Retroperitoneal soft-tissue sarcomas: prognosis and treatment of primary and recurrent disease. Ann Surg 66:832–836

    CAS  Google Scholar 

  27. Mantel N, Haenszel W (1959) Statistical aspect of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748

    PubMed  CAS  Google Scholar 

  28. Cody HS 3rd, Turnbull AD, Fortner JG, Hajdu SI (1981) The continuing challenge of retroperitoneal sarcomas. Cancer 47:2147–2152

    Article  PubMed  Google Scholar 

  29. Heslin MJ, Lewis JJ, Nadler E, Newman E, Woodruff JM, Casper ES, Leung D, Brennan MF (1997) Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol 15:2832–2839

    PubMed  CAS  Google Scholar 

  30. Alvarenga JC, Ball AB, Fisher C, Fryatt I, Jones L, Thomas JM (1991) Limitations of surgery in the treatment of retroperitoneal sarcomas. Br J Surg 78:912–916

    Article  PubMed  CAS  Google Scholar 

  31. Kilkenny JW III, Bland KI, Copeland EM III (1996) Retroperitoneal sarcoma: the University of Florida experience. J Am Coll Surg 182:329–339

    PubMed  Google Scholar 

  32. Karakousis CP, Velez AF, Gerstenbluth R, Driscoll DL (1996) Resecability and survival in retroperitoneal sarcomas. Ann Surg Oncol 3:150–158

    Article  PubMed  CAS  Google Scholar 

  33. Lahat G, Madewell JE, Anaya DA, Qiao W, Tuvin D, Benjamin RS, Lev DC, Pollock RE (2009) Computed tomography scan-driven selection of treatment for retroperitoneal liposarcoma histologic subtypes. Cancer 115(5):1081–1090

    Article  PubMed  Google Scholar 

  34. Bidault FJ, Vanel D, Athanasiou A, Pigneur F, Lopez I, Petrow P, Sigal R, Bonvalot S (2006) Retroperitoneal sarcomas imaging. Bull Cancer 93(12):1167–1174

    PubMed  Google Scholar 

  35. Kim EY, Kim SJ, Choi D, Lee SJ, Kim SH, Lim HK, Song SY (2008) Recurrence of retroperitoneal liposarcoma: imaging findings and growth rates at follow-up CT. AJR Am J Roentgenol 191(6):1841–1846

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marco Milone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Milone, M., Pezzullo, L.S., Salvatore, G. et al. Management of high-grade retroperitoneal liposarcomas: personal experience. Updates Surg 63, 119–124 (2011). https://doi.org/10.1007/s13304-011-0061-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13304-011-0061-z

Keywords

Navigation